FFundación Botín
Fundación Botín is a Santander-based private foundation, created in 1964, that invests in early-stage biotechnology through Mind the Gap, its technology-transfer programme launched in 2011. The programme backs nascent life-sciences companies built on technology from Spanish research institutions, investing up to €500,000 per project over a period of up to two years. Each company is also paired with an expert advisor appointed by the foundation. Since launch, Mind the Gap has invested about €6.3M, and its companies have raised more than €20M in private capital. Portfolio companies include Nostrum Biodiscovery, Life Length, Gate2Brain, Vaxdyn, MiWEndo Solutions, Innitius, Epidisease and Textia Innovative Solutions.
SectorsBiotechnology, Life Sciences, Healthcare, Medtech
VC MapSeed
Team
M
Marisa Tejedor
Technology Transfer Manager
Portfolio companies 7
Open 7 as list → On map →Funding rounds 7
Open as list →| Date | Company | Round | Amount | Lead |
|---|---|---|---|---|
| 2023-10-10 | Renalyse | Seed (estimated) | €1M |
Mind the Gap (Fundación Botín)
+2 more
|
| 2023-05-11 | Oniria Therapeutics | Seed | €1.28M |
Mind the Gap
+2 more
|
| 2023-02-15 | Innitius | Series A (estimated) | €1.8M |
Clave Capital, Nara Capital
+5 more
|
| 2021-03-08 | Vaxdyn | Seed (estimated) | €700K |
Lead unknown
+3 more
|
| 2020-07-09 | Gate2Brain | Seed (estimated) | €500K | Fundación Botín (Mind the Gap) |
| 2020-06-23 | MiWEndo Solutions | Seed (estimated) | €1.3M |
Lead unknown
+2 more
|
| 2018-07-25 | Innitius | Pre-seed | €500K | Fundación Botín (Mind the Gap) |
Often invests with 8
Open as list →News 3
Open as list →| Published | Article |
|---|---|
| 2026-06-18 |
Gate2Brain: Shilpa Biocare Invests €7 Million To Advance Brain Cancer Therapeutic Candidate ↗
Pulse 2.0
2026-06-18 |
| 2025-05-29 |
Ya hay casi 200 spin-offs biomédicas, pero se necesita más financiación ↗
Emprendedores
2025-05-29 |
| 2024-02-08 |
La Fundación Botín lanza una nueva convocatoria de su programa Mind the Gap para invertir 2 M€ en cuatro nuevos proyectos biotecnológicos ↗
Farmabiotec
2024-02-08 |








